Selective Internal Radiotherapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Cholangiocellular Carcinoma (CCC).
|ClinicalTrials.gov Identifier: NCT01798147|
Recruitment Status : Unknown
Verified May 2017 by Michael Bernhard Pitton, Johannes Gutenberg University Mainz.
Recruitment status was: Recruiting
First Posted : February 25, 2013
Last Update Posted : May 23, 2017
|Condition or disease||Intervention/treatment||Phase|
|Intrahepatic Cholangiocellular Carcinoma||Procedure: DEB TACE Procedure: SIRT||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||24 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Selective Internal Radiotherapy (SIRT) Versus Transarterial Chemoembolisation (TACE) for the Treatment of Cholangiocellular Carcinoma (CCC).|
|Study Start Date :||February 2011|
|Estimated Primary Completion Date :||June 2018|
|Estimated Study Completion Date :||June 2018|
Active Comparator: DEB TACE
Drug eluting Beads (DC Beads) loaded with Doxorubicin
Procedure: DEB TACE
DEB TACE every 6 weeks until either no viable tumor or endpoint reached.
Other Name: Chemoembolisation
Selective Internal Radiotherapy using Yttrium 90 loaded resin beads (Sir Spheres)
Selective Internal Radiotherapy once at the beginning of the study. Follow up until endpoint.
Other Name: Radioembolisation
- Progression-free survival (PFS) [ Time Frame: at the end of study ]
- Overall survival (OS) [ Time Frame: at the end of study ]
- Time to progression (TTP) [ Time Frame: at the end of study ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01798147
|Contact: Roman Kloeckner, MD||++49613117 ext firstname.lastname@example.org|
|Department of Diagnostic and Interventional Radiology||Recruiting|
|Mainz, Germany, 55131|
|Contact: Roman Kloeckner, MD ++49613117 ext 2019 email@example.com|